Prizma purchase experience, page-44

First 44 Last

Share
Profile

Follow
RA_86_99

514 Posts.

151

09/05/18

16:03

Post #: 32987509
Share

Originally posted by Ruby15 ↑

Hi RA,

I don't think the CEO's newsletter will come out until Friday. This way he can provide an update on how GMV is received at the big Medical Conference. Lets hope there is a lot of interest from other countries not already on the GMV's band wagon.

There are a lot of share holders eager to glean whatever information that can be provided by Dr Yacov and his team.

These are the following updates that I am interested in:

a. Chinese approvals for the Prizma Sleeve & Patch and readiness of the Factory
b. FDA for the Patch in USA
c. TGA for Patch in Australia
d. Startup of IDTL in USA.
e. Will a capital raise will be needed, and
f. Anything in the pipeline for Nth America.

Its quite exhaustive and I would love to spend 1hr listening to Dr Yacov tell his own story with this little baby of his. I have watched the 40 min interview with Dr Yacov at least 5 times and I can just feel how excited he is to bring this whole idea of his to market.

I for will be along for the ride and I can't wait for the factory approval so we can get this whole show on the road.

GTLAH

Cheers Rubes

Expand

Great list.

Add to that:
(i) effect of CE approval of GMV algorithms - does this open up further opportunities
(ii) update on units sold
(iii) partnership with AU and/or NZ company
(iv) update on OTC for US Patch

heck - there is just so much!

GMV Price at posting: 28.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

AX8

Accelerate finds 1.28% lithium at Prinsep in WA, including 150m 'halo' zone

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

VMM

Virdis Mining flags breakthrough with 76% neodymium and praseodymium recoveries

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability